Calluna Pharma Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $82.2M

  • Investors
  • 12

Calluna Pharma General Information

Description

Operator of a clinical-stage company intended to develop novel therapies that harness the transformative potential of the body's immune system. The company involves precision targeting of upstream innate immune amplifiers and disruption of a comprehensive range of disease-associated downstream signaling pathways while maintaining a favorable safety profile, enabling novel therapeutic candidates to fulfill unmet clinical needs across a spectrum of diseases.

Contact Information

Website
www.callunapharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gaustadalléen 21
  • 0349 Oslo
  • Norway
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Gaustadalléen 21
  • 0349 Oslo
  • Norway

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Calluna Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 23-Jan-2024 $82.2M Completed Clinical Trials - Phase 2
2. Accelerator/Incubator Completed Clinical Trials - Phase 2
1. Merger of Equals 01-Jan-2023 Completed Clinical Trials - Phase 2
To view Calluna Pharma’s complete valuation and funding history, request access »

Calluna Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage company intended to develop novel therapies that harness the transformative potential of th
Drug Discovery
Oslo, Norway
25 As of 2026

London, United Kingdom
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Calluna Pharma Competitors (3)

One of Calluna Pharma’s 3 competitors is Quell Therapeutics, a Venture Capital-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Quell Therapeutics Venture Capital-Backed London, United Kingdom
Sitryx Venture Capital-Backed Oxford, United Kingdom
Resolution Therapeutics Venture Capital-Backed London, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Calluna Pharma Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Calluna Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024240129-A1 Anti-phosphocholine antibodies and methods of use thereof Pending 17-Mar-2023
EP-4680632-A2 Anti-phosphocholine antibodies and methods of use thereof Pending 17-Mar-2023
US-12291579-B2 Anti-phosphocholine antibodies and methods of use thereof Active 17-Mar-2023
US-20250034283-A1 Anti-phosphocholine antibodies and methods of use thereof Active 17-Mar-2023
US-20250320312-A1 Anti-phosphocholine antibodies and methods of use thereof Pending 17-Mar-2023 A61P9/10
To view Calluna Pharma’s complete patent history, request access »

Calluna Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Calluna Pharma Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andenes Investments Venture Capital Minority
ASTEROIDEBAKKEN Corporation Minority
Eurostars Other Minority
Forbion Venture Capital Minority
Investinor Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Calluna Pharma Acquisitions (2)

Calluna Pharma’s most recent deal was a Merger/Acquisition with Arxx Therapeutics. The deal was made on 25-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Arxx Therapeutics 25-Jan-2024 Merger/Acquisition Drug Discovery
Oxitope Pharma 22-Jan-2024 Merger/Acquisition Drug Discovery
To view Calluna Pharma’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Calluna Pharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Arxx Therapeutics Oslo, Norway 2015

Calluna Pharma FAQs

  • When was Calluna Pharma founded?

    Calluna Pharma was founded in 2023.

  • Where is Calluna Pharma headquartered?

    Calluna Pharma is headquartered in Oslo, Norway.

  • What is the size of Calluna Pharma?

    Calluna Pharma has 25 total employees.

  • What industry is Calluna Pharma in?

    Calluna Pharma’s primary industry is Drug Discovery.

  • Is Calluna Pharma a private or public company?

    Calluna Pharma is a Private company.

  • What is Calluna Pharma’s current revenue?

    The current revenue for Calluna Pharma is .

  • How much funding has Calluna Pharma raised over time?

    Calluna Pharma has raised $82.2M.

  • Who are Calluna Pharma’s investors?

    Andenes Investments, ASTEROIDEBAKKEN, Eurostars, Forbion, and Investinor are 5 of 12 investors who have invested in Calluna Pharma.

  • Who are Calluna Pharma’s competitors?

    Quell Therapeutics, Sitryx, and Resolution Therapeutics are competitors of Calluna Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process